8
Effective Partnerships Stuart Pritchard Senior Government Affairs & Policy Manager, GlaxoSmithKline UK 23rd February 2012

Why does industry engage with patient groups?

Embed Size (px)

DESCRIPTION

Patient Groups & Pharmaceutical Companies: Effective Partnerships Stuart Pritchard Senior Government Affairs & Policy Manager, GlaxoSmithKline UK 23rd February 2012. Why does industry engage with patient groups?. How does industry engage with patient groups?. - PowerPoint PPT Presentation

Citation preview

Page 1: Why does industry engage with patient groups?

Patient Groups & Pharmaceutical Companies: Effective Partnerships

Stuart PritchardSenior Government Affairs & Policy Manager, GlaxoSmithKline UK

23rd February 2012

Page 2: Why does industry engage with patient groups?

Why does industry engage with patient groups?

Page 3: Why does industry engage with patient groups?

How does industry engage with patient groups?

Page 4: Why does industry engage with patient groups?

GSK’s global patient advocacy principles

Page 5: Why does industry engage with patient groups?

GSK Funding & Disclosure

Page 6: Why does industry engage with patient groups?

Getting it right: ABPI Code of Practice (Clause 23)

Page 7: Why does industry engage with patient groups?

Getting it wrong

Page 8: Why does industry engage with patient groups?

Case Studies